[go: up one dir, main page]

ZA200006080B - Human BMP-7 promoter and method for exploring bone-related substance by using the same. - Google Patents

Human BMP-7 promoter and method for exploring bone-related substance by using the same.

Info

Publication number
ZA200006080B
ZA200006080B ZA200006080A ZA200006080A ZA200006080B ZA 200006080 B ZA200006080 B ZA 200006080B ZA 200006080 A ZA200006080 A ZA 200006080A ZA 200006080 A ZA200006080 A ZA 200006080A ZA 200006080 B ZA200006080 B ZA 200006080B
Authority
ZA
South Africa
Prior art keywords
promoter
same
related substance
human bmp
exploring
Prior art date
Application number
ZA200006080A
Other languages
English (en)
Inventor
Shinji Kawai
Takeyuki Sugiura
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA200006080B publication Critical patent/ZA200006080B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200006080A 1998-04-30 2000-10-27 Human BMP-7 promoter and method for exploring bone-related substance by using the same. ZA200006080B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10120174A JPH11313675A (ja) 1998-04-30 1998-04-30 ヒトｂｍｐ−７プロモーターおよびこれを用いた骨関連物質の探索法

Publications (1)

Publication Number Publication Date
ZA200006080B true ZA200006080B (en) 2001-10-29

Family

ID=14779761

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200006080A ZA200006080B (en) 1998-04-30 2000-10-27 Human BMP-7 promoter and method for exploring bone-related substance by using the same.

Country Status (26)

Country Link
US (2) US6534268B1 (et)
EP (1) EP1076713A1 (et)
JP (1) JPH11313675A (et)
KR (1) KR20010071193A (et)
CN (1) CN1170941C (et)
AP (1) AP1329A (et)
AU (1) AU769124B2 (et)
BG (1) BG64780B1 (et)
BR (1) BR9910585A (et)
CA (1) CA2326957A1 (et)
EA (1) EA004509B1 (et)
EE (1) EE200000627A (et)
GE (1) GEP20033056B (et)
HR (1) HRP20000736A2 (et)
HU (1) HUP0102329A3 (et)
ID (1) ID26704A (et)
IL (1) IL139100A0 (et)
NO (1) NO20005433D0 (et)
NZ (1) NZ507625A (et)
PL (1) PL343817A1 (et)
SK (1) SK16082000A3 (et)
TR (1) TR200003182T2 (et)
UA (1) UA72212C2 (et)
WO (1) WO1999057293A1 (et)
YU (1) YU64900A (et)
ZA (1) ZA200006080B (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20070015701A1 (en) * 2005-06-01 2007-01-18 Samuel Zalipsky Macromolecular conjugates of bone morphogenetic protein-7
SI2078073T1 (sl) * 2006-10-12 2013-11-29 Ethicon, Inc. Celice, pridobljene iz ledvice, in postopki uporabe pri popravljanju tkiv in regeneraciji
EP2293808B1 (en) * 2008-05-16 2012-08-15 Industry Foundation Of Chonnam National University An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
KR20130110143A (ko) 2010-06-09 2013-10-08 셈프러스 바이오사이언시스 코퍼레이션 방오성, 항균성, 항혈전성 그라프트-프롬 조성물
EP2579906A4 (en) 2010-06-09 2016-03-23 Arrow Int Inc ARTICLES HAVING NON-CLASSING SURFACES AND METHODS FOR PREPARING THEM WITHOUT ALTERING GENERAL PHYSICAL PROPERTIES
US20110305898A1 (en) 2010-06-09 2011-12-15 Zheng Zhang Non-fouling, anti-microbial, anti-thrombogenic graft compositions
US9511071B2 (en) 2010-08-18 2016-12-06 Emory University Compounds and compositions for ossification and methods related thereto
US9295754B2 (en) 2011-02-24 2016-03-29 Emory University Noggin inhibitory compositions for ossification and methods related thereto
CA2826773C (en) 2011-02-24 2019-07-16 Emory University Jab1 blocking compositions for ossification and methods related thereto
MX2014007211A (es) 2011-12-14 2015-04-14 Semprus Biosciences Corp Lente de contacto de hidrogel de silicona modificada usando oxidantes de lantanido o de metal de transicion.
MX2014007202A (es) 2011-12-14 2015-03-09 Semprus Biosciences Corp Lentes de contacto modificadas en la superficie.
EP2791214A4 (en) 2011-12-14 2015-11-04 Semprus Biosciences Corp REDOX PROCESS FOR CONTACT LENS MODIFICATION
MX2014007203A (es) 2011-12-14 2015-04-14 Semprus Biosciences Corp Proceso de imbibicion para modificacion de superficie de lente de contacto.
WO2013090801A1 (en) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Multistep uv process to create surface modified contact lenses
WO2019005563A1 (en) * 2017-06-27 2019-01-03 St. Jude Children's Research Hospital METHODS ASSOCIATED WITH THE ACTIVATION OF THE SIGNALING PATHWAY OF BONE MORPHOGENETIC PROTEINS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
ES2113857T3 (es) * 1989-03-28 1998-05-16 Genetics Inst Composiciones osteoinductoras.
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
WO1993003382A2 (en) * 1991-08-01 1993-02-18 Pharmaceutical Discovery Corporation Characterization of specific drug receptors with fluorescent ligands
EP0804573A1 (en) * 1994-06-07 1997-11-05 Creative Biomolecules, Inc. Methods and compositions for modulating morphogenic protein expression
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
BR9713130A (pt) 1996-11-22 2000-02-08 Akzo Nobel Nv Região promotora de bmp-4 e seus fragmentos, vetor compreendendo uma região promotora de bmp-4 ou seus fragmentos, célula hospedeira, processo para a identificação de agentes terapêuticos para a prevenção e/ou tratamento da osteoporose, e, uso de ici 164384.
US5863790A (en) 1997-05-14 1999-01-26 Minnesota Mining And Manfacturing Company Biological sterility indicator
JP2001517092A (ja) * 1997-05-29 2001-10-02 クリエイティブ バイオモレキュールズ，インコーポレイテッド モルフォゲン発現のモジュレーターおよびモジュレーターを同定する方法

Also Published As

Publication number Publication date
JPH11313675A (ja) 1999-11-16
BR9910585A (pt) 2001-01-09
YU64900A (sh) 2003-10-31
ID26704A (id) 2001-02-01
CN1170941C (zh) 2004-10-13
SK16082000A3 (sk) 2001-05-10
NO20005433L (no) 2000-10-27
IL139100A0 (en) 2001-11-25
NZ507625A (en) 2003-12-19
WO1999057293A1 (en) 1999-11-11
AU769124B2 (en) 2004-01-15
HRP20000736A2 (en) 2001-10-31
AP1329A (en) 2004-11-22
EA200001130A1 (ru) 2001-04-23
EE200000627A (et) 2002-02-15
PL343817A1 (en) 2001-09-10
HUP0102329A3 (en) 2006-03-28
US6534268B1 (en) 2003-03-18
BG104883A (en) 2001-05-31
AP2000001982A0 (en) 2000-12-31
BG64780B1 (bg) 2006-03-31
GEP20033056B (en) 2003-08-25
EA004509B1 (ru) 2004-04-29
EP1076713A1 (en) 2001-02-21
TR200003182T2 (tr) 2001-02-21
CA2326957A1 (en) 1999-11-11
US20030040007A1 (en) 2003-02-27
KR20010071193A (ko) 2001-07-28
CN1307643A (zh) 2001-08-08
NO20005433D0 (no) 2000-10-27
HUP0102329A2 (hu) 2001-10-28
AU3163499A (en) 1999-11-23
UA72212C2 (en) 2005-02-15

Similar Documents

Publication Publication Date Title
SG71077A1 (en) 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
ZA977948B (en) Process for the control of weeds.
ZA988465B (en) Nickel-containing compounds useful as electrodes and method for preparing same.
ZA200006080B (en) Human BMP-7 promoter and method for exploring bone-related substance by using the same.
ZA981032B (en) Separation apparatus.
ZA986645B (en) Emulsion.
ZA978011B (en) Drilling apparatus.
ZA972509B (en) Distillation apparatus.
ZA985026B (en) Method for enhancing the activity of an enzyme.
ZA971272B (en) Gene expression.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA961082B (en) DNA sequence.
ZA971263B (en) Diagnostic method.
ZA9710114B (en) Method for the expression of genes.
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
ZA982436B (en) Thiazolimine derivatives.
EP0999848A4 (en) CHIMEAN PROTEINS FOR TREATING DIABETES
AU3163599A (en) Human bmp-2 promoter and method for exploring bone-related substance by using the same
ZA989719B (en) Polymorphs.
ZA988637B (en) Methods for regulating trkA expression.
PL344526A1 (en) Human bmp-4 promoter and method for exploring bone-related substance by using the same
ZA981329B (en) Separation apparatus.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA977791B (en) GLP-1 derivatives.